Tactile Systems Technology Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Tactile Systems Technology Inc 's ROA in the second quarter of 2026?
Tactile Systems Technology Inc achieved a return on average assets (ROA) of 9.17 % in its second quarter of 2026, this is above TCMD's average return on assets of 3.3%.
Tactile Systems Technology Inc assets over the 12 months ending in its second quarter of 2026 are valued at $271 million

ROA has improved compared to 7.53% in the first quarter of 2026, due to net income growth.

However, within the Healthcare sector 103 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 831, from total ROA ranking in the first quarter of 2026 at 1035.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	2.42 %	-2.9 %	-8.05 %	-9.39 %	-1.25 %
Y / Y Net Income Change	142 %	-	9.45 %	59.24 %	-25.15 %
Net Income (TTM) in million	25	20	19	18	15
Return On Assets (TTM)	9.17 %	7.53 %	7.03 %	6.54 %	5.32 %
TCMD's Total Ranking	# 831	# 1035	# 939	# 1124	# 1080
Total Assets (TTM) in million	280	272	274	259	273
Seq. Total Assets Change	2.78 %	-0.67 %	5.7 %	-5.08 %	-2.57 %
Seq. Net Income Change	-	-	29.54 %	155.18 %	-

TCMD's 5 Years Annual ROA >> Back to TCMD Management Effectiveness >> Compare TCMD ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 31
Sector	# 104
Overall	# 659

Return On Assets Statistics
High	Average	Low
11.58 %	3.3 %	-12.89 %
(Jun 30 2024)		(Jun 30 2022)

News about Tactile Systems Technology Inc Return on Assets ROA

Tactile Medicals Bold Moves: New Board Appointment and Cutting-Edge Lymphedema Technology Signal Strategic Growth in Chronic Care Management,

Tactile Medical s Strategic Moves: A New Board Member and Innovative Therapies Signal Growth Amid Rising Demand for Chronic Care SolutionsBy CSI Market Reporter MINNEAPOLIS, MN — On January 13, 2025, Tactile Systems Technology, Inc. (Nasdaq: TCMD), a rapidly evolving player in the medical technology sector, announced the appointment of Laura King to its Board of Directors. This move comes at a pivotal time for the company, which is capitalizing on an increasing demand for effective treatments for chronic conditions like lymphedema—a condition often tagging along with the enhancements in cancer treatment success.King s addition to the Board, where she will also serve on the Audit and Compliance and Reimbursement Committees, suggests a strategic shift towards bolstering governance and compliance as Tactile Medical navigates a complex landscape of medical reimbursement policies and regulatory oversight. Industry insider opinions on this appointment reflect the confidence that King—who brings extensive experience in corporate governance and financial oversight—may inject into Tactile’s mission of delivering impactful medical solutions amidst financial growth.

In a significant breakthrough in the treatment of lymphedema, Tactile Medical has announced the launch of i...

Innovative Technology to Address Upper Extremity Lymphedema: Tactile Medical Unveils Next-Generation Nimbl Platform In a significant breakthrough in the treatment of lymphedema, Tactile Medical has announced the launch of its next-generation Nimbl platform. This state-of-the-art technology is set to transform the care provided to patients suffering from upper extremity lymphedema, a condition that can significantly impact the quality of life for those affected.Lymphedema, a chronic condition characterized by the swelling and retention of lymph fluid, often arises as a result of lymphatic system damage, which can occur following cancer treatments, surgeries, or infections. It is most commonly associated with breast cancer survivors who have undergone lymph node removal or radiation therapy. As medical advancements increase cancer survival rates, the number of individuals living with chronic conditions like lymphedema is also rising, presenting a growing need for effective management solutions.

Financial Statements
Tactile Systems Technology Inc 's Assets	$ 280 million	TCMD's Balance sheet
Tactile Systems Technology Inc 's Income	$ 8 million	Quarterly TCMD's Income Statement
TCMD's Income by Division		See TCMD's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-8.05 %	9.42 %	17.22 %	-0.5 %	39.58 %
Total Assets in million	274	298	272	232	233
Y / Y Net Income Change	12.54 %	-40.52 %	-	-	-
Net Income in million	19	17	29	-18	-12
Annual Return On Assets	6.97 %	5.69 %	10.47 %	-7.69 %	-5.06 %

TCMD's 5 Years Annual ROA >> Back to TCMD Management Effectiveness >> Compare TCMD ROA to its Competitors

Comment on TCMD's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 6.97 % compared to prior year, due to annual net income growth of 12.54 % to $19.09 million, and due to decline of value in Tactile Systems Technology Inc 's assets by -8.05 % to $273.94 million, compared to $273.94 a year before.

More Return On Assets Ratios
TCMD's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
TCMD's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for TCMD's Competitors
Subscribers only: Roa for Tactile Systems Technology Inc 's Suppliers
Subscribers only: Return On Assets for TCMD's Customers

You may also want to know
TCMD's Roi	TCMD's Inventory Turnover Ratio	TCMD's Growth Rates	TCMD's Dividend Comparisons
	TCMD's Profitability Ratios	TCMD's Asset Turnover Ratio	TCMD's Dividend Growth
TCMD's Roe	TCMD's Valuation Ratios	TCMD's Financial Strength Ratios	TCMD's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Mettler toledo International Inc	24.86 %
Medpace Holdings Inc	24.84 %
Caredx Inc	24.81 %
Acadia Pharmaceuticals Inc	24.38 %
Eli Lilly And Company	21.97 %
Innoviva Inc	21.64 %
Vaxart Inc	20.85 %
Zevra Therapeutics Inc	20.39 %
Iradimed Corporation	20.36 %
Protalix Biotherapeutics inc	20.09 %
Pro dex Inc	19.87 %
Electromed Inc	19.39 %
United Therapeutics Corporation	17.98 %
Resmed Inc	17.80 %
Krystal Biotech Inc	17.65 %
Chemed Corporation	17.52 %
Zoetis Inc	17.19 %
Vertex Pharmaceuticals Inc	16.88 %
Halozyme Therapeutics Inc	16.55 %
Alnylam Pharmaceuticals Inc	15.76 %
Intuitive Surgical Inc	15.63 %
Healthcare Services Group Inc	15.21 %
Inspire Medical Systems inc	15.21 %
Dexcom Inc	14.87 %
Neurocrine Biosciences Inc	14.73 %
Entera Bio Ltd	14.60 %
Standard Biotools Inc	14.31 %
Arcutis Biotherapeutics Inc	14.23 %
Harmony Biosciences Holdings inc	14.15 %
Biolife Solutions Inc	14.09 %

Date modified: 2026-09-02T17:59:40+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.